Financial resul...
login
Shares
Bonds
π₯Pre-IPO
Dividends
Portfolio
More
ETF
Sectors
News
Calendar
Try for free
Login
×
Email
Password
Forgot your password?
Login
Resend my activation email
Need an account? Sign up.
Home
News
BioLineRx
Financial results
2/24/21 at 00:32
Share at
News editor
press@blackterminal.com
BioLineRx's IFRS loss for 2020 was $30.021 million, up 18% from $25.446 million the previous year.
BioLineRx
BLRX
$1.38
+15.00%
Review
Source:
ir.biolinerx.com
News editor
Share at:
Share this news
×
To leave a comment, you must be logged in
Write your comment first
News feed
MOEX Group's commission income increased almost 1.5 times in the first quarter
5/22/24
MOEX
Element Group will be listed on the stock exchange on May 30
5/22/24
SPBE
Inter RAO may build new power plants in Siberia
5/21/24
IRAO
Board of Directors of Rosseti Volga recommended that dividends be paid for 2023
5/21/24
MRKV
Board of Directors of Gazprom Neft recommended that dividends be paid for 2023
5/21/24
SIBN
Russian equivalent of Miro and FigJam attracts investment
5/21/24
OTCI
Shareholders of Tattelecom approved dividends for 2023
5/21/24
TTLK
Rostelecom plans IPO of subsidiary RTK-DPC in autumn
5/21/24
RTKM
Gazprom won't pay any dividends this year
5/21/24
GAZP
Board of Directors of Rosseti Lenenergo recommended that dividends be paid for 2023
5/20/24
LSNG
«
Previous
3
4
5
6
7
8
9
10
11
12
»
Next
BlackTerminal.com 2016 - 2024.
English (US)
English (US)
Π ΡΡΡΠΊΠΈΠΉ (Π Π€)